75 related articles for article (PubMed ID: 25885128)
21. Carboplatin in the treatment of Ewing sarcoma: Results of the first Brazilian collaborative study group for Ewing sarcoma family tumors-EWING1.
Brunetto AL; Castillo LA; Petrilli AS; Macedo CD; Boldrini E; Costa C; Almeida MT; Kirst D; Rodriguez-Galindo C; Pereira WV; Watanabe FM; Pizza M; Benites E; Morais V; Gadelha A; Nakasato A; Abujamra AL; Gregianin LJ;
Pediatr Blood Cancer; 2015 Oct; 62(10):1747-53. PubMed ID: 25917418
[TBL] [Abstract][Full Text] [Related]
22. Clinical features and outcomes of infants with Ewing sarcoma under 12 months of age.
Wong T; Goldsby RE; Wustrack R; Cash T; Isakoff MS; DuBois SG
Pediatr Blood Cancer; 2015 Nov; 62(11):1947-51. PubMed ID: 26173989
[TBL] [Abstract][Full Text] [Related]
23. [Influence of tumor-associated macrophages on progression and prognosis of nasopharyngeal carcinoma].
Peng J; Ding T; Zheng LM; Shao JY
Ai Zheng; 2006 Nov; 25(11):1340-5. PubMed ID: 17094898
[TBL] [Abstract][Full Text] [Related]
24. Etoposide and carbo-or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: a large retrospective study.
van Maldegem AM; Benson C; Rutkowski P; Blay JY; van den Berg H; Placzke J; Rasper M; Judson I; Juergens H; Dirksen U; Gelderblom H
Pediatr Blood Cancer; 2015 Jan; 62(1):40-4. PubMed ID: 25251256
[TBL] [Abstract][Full Text] [Related]
25. Survival and prognostic factors in adult patients with recurrent or refractory ewing sarcoma family tumours: a 13-years retrospective study in Turkey.
Yildiz I; Sen F; Ekenel M; Darendeliler E; Bavbek S; Agaoglu F; Ozger H; Eralp L; Bilgic B; Basaran M
In Vivo; 2014; 28(3):403-9. PubMed ID: 24815845
[TBL] [Abstract][Full Text] [Related]
26. Extraskeletal Ewing's sarcoma family of tumors in adults: prognostic factors and clinical outcome.
Tural D; Molinas Mandel N; Dervisoglu S; Oner Dincbas F; Koca S; Colpan Oksuz D; Kantarci F; Turna H; Selcukbiricik F; Hiz M
Jpn J Clin Oncol; 2012 May; 42(5):420-6. PubMed ID: 22416252
[TBL] [Abstract][Full Text] [Related]
27. An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas.
Dickinson AJ; Fox SB; Newcomb PV; Persad RA; Sibley GN; Harris AL
J Urol; 1995 Jul; 154(1):237-41. PubMed ID: 7776437
[TBL] [Abstract][Full Text] [Related]
28. Expression of c-kit in Ewing family of tumors: a comparison of different immunohistochemical protocols.
Ahmed A; Gilbert-Barness E; Lacson A
Pediatr Dev Pathol; 2004; 7(4):342-7. PubMed ID: 15383930
[TBL] [Abstract][Full Text] [Related]
29. The significance of the co-existence of osteopontin and tumor-associated macrophages in gastric cancer progression.
Lin CN; Wang CJ; Chao YJ; Lai MD; Shan YS
BMC Cancer; 2015 Mar; 15():128. PubMed ID: 25872762
[TBL] [Abstract][Full Text] [Related]
30. Expression of CCL21 in Ewing sarcoma shows an inverse correlation with metastases and is a candidate target for immunotherapy.
Sand LG; Berghuis D; Szuhai K; Hogendoorn PC
Cancer Immunol Immunother; 2016 Aug; 65(8):995-1002. PubMed ID: 27369431
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors in primary nonmetastatic Ewing sarcoma of the rib in children and young adults.
Qureshi SS; Kembhavi S; Vora T; Ramadwar M; Laskar S; Talole S; Kurkure P
J Pediatr Surg; 2013 Apr; 48(4):764-70. PubMed ID: 23583131
[TBL] [Abstract][Full Text] [Related]
32. SMARCA4 (BRG1) loss of expression is a useful marker for the diagnosis of ovarian small cell carcinoma of the hypercalcemic type (ovarian rhabdoid tumor): a comprehensive analysis of 116 rare gynecologic tumors, 9 soft tissue tumors, and 9 melanomas.
Karanian-Philippe M; Velasco V; Longy M; Floquet A; Arnould L; Coindre JM; Le Naoures-Méar C; Averous G; Guyon F; MacGrogan G; Croce S
Am J Surg Pathol; 2015 Sep; 39(9):1197-205. PubMed ID: 26135561
[TBL] [Abstract][Full Text] [Related]
33. Loss of MTAP expression is a negative prognostic marker in Ewing sarcoma family of tumors.
Abrahao-Machado LF; Antunes B; Filippi RZ; Volc S; Boldrini E; Menezes WP; Reis RM; de Camargo OP
Biomark Med; 2018 Jan; 12(1):35-44. PubMed ID: 29243509
[TBL] [Abstract][Full Text] [Related]
34. Cathepsin L is highly expressed in gastrointestinal stromal tumors.
Miyamoto K; Iwadate M; Yanagisawa Y; Ito E; Imai J; Yamamoto M; Sawada N; Saito M; Suzuki S; Nakamura I; Ohki S; Saze Z; Kogure M; Gotoh M; Omicronbara K; Ohira H; Tasaki K; Abe M; Goshima N; Watanabe S; Waguri S; Takenoshita S
Int J Oncol; 2011 Nov; 39(5):1109-15. PubMed ID: 21769426
[TBL] [Abstract][Full Text] [Related]
35. Risk of recurrence and survival after relapse in patients with Ewing sarcoma.
Stahl M; Ranft A; Paulussen M; Bölling T; Vieth V; Bielack S; Görtitz I; Braun-Munzinger G; Hardes J; Jürgens H; Dirksen U
Pediatr Blood Cancer; 2011 Oct; 57(4):549-53. PubMed ID: 21442722
[TBL] [Abstract][Full Text] [Related]
36. Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults.
Dantonello TM; Int-Veen C; Harms D; Leuschner I; Schmidt BF; Herbst M; Juergens H; Scheel-Walter HG; Bielack SS; Klingebiel T; Dickerhoff R; Kirsch S; Brecht I; Schmelzle R; Greulich M; Gadner H; Greiner J; Marky I; Treuner J; Koscielniak E
J Clin Oncol; 2009 Mar; 27(9):1446-55. PubMed ID: 19224858
[TBL] [Abstract][Full Text] [Related]
37. Ewing's sarcoma family of tumors in Finland during 1990-2009: a population-based study.
Serlo JA; Helenius IJ; Sampo M; Vettenranta K; Saarinen-Pihkala UM; Kivivuori SM; Riikonen P; Kivioja A; Böhling T; Kallajoki M; Ristimäki A; Vasama K; Tarkkanen M
Acta Oncol; 2013 May; 52(4):767-75. PubMed ID: 23173760
[TBL] [Abstract][Full Text] [Related]
38. The value of high-dose chemotherapy in patients with first relapsed Ewing sarcoma.
Rasper M; Jabar S; Ranft A; Jürgens H; Amler S; Dirksen U
Pediatr Blood Cancer; 2014 Aug; 61(8):1382-6. PubMed ID: 24729428
[TBL] [Abstract][Full Text] [Related]
39. Angiogenesis and Ewing sarcoma--relationship to pulmonary metastasis and survival.
Mikulić D; Ilić I; Cepulić M; Giljević JS; Orlić D; Zupancić B; Fattorini I; Seiwerth S
J Pediatr Surg; 2006 Mar; 41(3):524-9. PubMed ID: 16516628
[TBL] [Abstract][Full Text] [Related]
40. Unusual sites of Ewing sarcoma (ES): a retrospective multicenter 30-year experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP) and Italian Sarcoma Group (ISG).
Berger M; Fagioli F; Abate M; Riccardi R; Prete A; Cozza R; Bertulli R; Podda M; Ferrari S; Luksch R
Eur J Cancer; 2013 Nov; 49(17):3658-65. PubMed ID: 23890769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
